Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof
申请人:Tumey Nathan L.
公开号:US20070191342A1
公开(公告)日:2007-08-16
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5-HT
2c
) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT
2c
) is desired (e.g. addiction, anxiety, depression, obesity, and others).
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF
申请人:Tumey L. Nathan
公开号:US20110112072A1
公开(公告)日:2011-05-12
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5-HT
2c
) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT
2c
) is desired (e.g. addiction, anxiety, depression, obesity, and others).
Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
申请人:Tumey L. Nathan
公开号:US08716276B2
公开(公告)日:2014-05-06
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).